CHE Quote, Financials, Valuation and Earnings

AMN Healthcare Services, Inc. has a net margin of 10.28% compared to Chemed Corp.'s net margin of 4.62%. Chemed Corp.'s return on equity of 23.99% beat AMN Healthcare Services, Inc.'s return on equity of -38.65%.

Chemed Corp. has a consensus price target of $555.50, signalling upside risk potential of 17.39%. On the other hand AMN Healthcare Services, Inc. has an analysts' consensus of $20.86 which suggests that it could grow by 28.35%. Given that AMN Healthcare Services, Inc. has higher upside potential than Chemed Corp., analysts believe AMN Healthcare Services, Inc. is more attractive than Chemed Corp..

Chemed Corp. has a beta of 0.440, which suggesting that the stock is 56.018% less volatile than S&P 500. In comparison AMN Healthcare Services, Inc. has a beta of 0.225, suggesting its less volatile than the S&P 500 by 77.507%.

Chemed Corp. has a quarterly dividend of $0.60 per share corresponding to a yield of 0.47%. AMN Healthcare Services, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Chemed Corp. pays 9.05% of its earnings as a dividend. AMN Healthcare Services, Inc. pays out -- of its earnings as a dividend. Chemed Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Chemed Corp. quarterly revenues are $624.9M, which are smaller than AMN Healthcare Services, Inc. quarterly revenues of $634.5M. Chemed Corp.'s net income of $64.2M is higher than AMN Healthcare Services, Inc.'s net income of $29.3M. Notably, Chemed Corp.'s price-to-earnings ratio is 25.02x while AMN Healthcare Services, Inc.'s PE ratio is 18.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Chemed Corp. is 2.75x versus 0.23x for AMN Healthcare Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Humana, Inc. has a net margin of 10.28% compared to Chemed Corp.'s net margin of -2.39%. Chemed Corp.'s return on equity of 23.99% beat Humana, Inc.'s return on equity of 6.77%.

Chemed Corp. has a consensus price target of $555.50, signalling upside risk potential of 17.39%. On the other hand Humana, Inc. has an analysts' consensus of $230.25 which suggests that it could grow by 25.78%. Given that Humana, Inc. has higher upside potential than Chemed Corp., analysts believe Humana, Inc. is more attractive than Chemed Corp..

Chemed Corp. has a beta of 0.440, which suggesting that the stock is 56.018% less volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.437, suggesting its less volatile than the S&P 500 by 56.287%.

Chemed Corp. has a quarterly dividend of $0.60 per share corresponding to a yield of 0.47%. Humana, Inc. offers a yield of 1.92% to investors and pays a quarterly dividend of $0.89 per share. Chemed Corp. pays 9.05% of its earnings as a dividend. Humana, Inc. pays out 35.98% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Chemed Corp. quarterly revenues are $624.9M, which are smaller than Humana, Inc. quarterly revenues of $32.5B. Chemed Corp.'s net income of $64.2M is higher than Humana, Inc.'s net income of -$776M. Notably, Chemed Corp.'s price-to-earnings ratio is 25.02x while Humana, Inc.'s PE ratio is 18.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Chemed Corp. is 2.75x versus 0.17x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Option Care Health, Inc. has a net margin of 10.28% compared to Chemed Corp.'s net margin of 3.61%. Chemed Corp.'s return on equity of 23.99% beat Option Care Health, Inc.'s return on equity of 15.16%.

Chemed Corp. has a consensus price target of $555.50, signalling upside risk potential of 17.39%. On the other hand Option Care Health, Inc. has an analysts' consensus of $39.82 which suggests that it could grow by 12.42%. Given that Chemed Corp. has higher upside potential than Option Care Health, Inc., analysts believe Chemed Corp. is more attractive than Option Care Health, Inc..

Chemed Corp. has a beta of 0.440, which suggesting that the stock is 56.018% less volatile than S&P 500. In comparison Option Care Health, Inc. has a beta of 0.842, suggesting its less volatile than the S&P 500 by 15.789%.

Chemed Corp. has a quarterly dividend of $0.60 per share corresponding to a yield of 0.47%. Option Care Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Chemed Corp. pays 9.05% of its earnings as a dividend. Option Care Health, Inc. pays out -- of its earnings as a dividend. Chemed Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Chemed Corp. quarterly revenues are $624.9M, which are smaller than Option Care Health, Inc. quarterly revenues of $1.4B. Chemed Corp.'s net income of $64.2M is higher than Option Care Health, Inc.'s net income of $51.8M. Notably, Chemed Corp.'s price-to-earnings ratio is 25.02x while Option Care Health, Inc.'s PE ratio is 28.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Chemed Corp. is 2.75x versus 1.06x for Option Care Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Regional Health Properties, Inc. has a net margin of 10.28% compared to Chemed Corp.'s net margin of 22.34%. Chemed Corp.'s return on equity of 23.99% beat Regional Health Properties, Inc.'s return on equity of --.

Chemed Corp. has a consensus price target of $555.50, signalling upside risk potential of 17.39%. On the other hand Regional Health Properties, Inc. has an analysts' consensus of -- which suggests that it could grow by 396.18%. Given that Regional Health Properties, Inc. has higher upside potential than Chemed Corp., analysts believe Regional Health Properties, Inc. is more attractive than Chemed Corp..

Chemed Corp. has a beta of 0.440, which suggesting that the stock is 56.018% less volatile than S&P 500. In comparison Regional Health Properties, Inc. has a beta of 1.022, suggesting its more volatile than the S&P 500 by 2.199%.

Chemed Corp. has a quarterly dividend of $0.60 per share corresponding to a yield of 0.47%. Regional Health Properties, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Chemed Corp. pays 9.05% of its earnings as a dividend. Regional Health Properties, Inc. pays out -- of its earnings as a dividend. Chemed Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Chemed Corp. quarterly revenues are $624.9M, which are larger than Regional Health Properties, Inc. quarterly revenues of $15.1M. Chemed Corp.'s net income of $64.2M is higher than Regional Health Properties, Inc.'s net income of $3.4M. Notably, Chemed Corp.'s price-to-earnings ratio is 25.02x while Regional Health Properties, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Chemed Corp. is 2.75x versus 0.08x for Regional Health Properties, Inc.. Usually stocks with elevated PS ratios are considered overvalued.